Title:
【発明の名称】造血細胞のCXCR4アンタゴニスト治療
Document Type and Number:
Japanese Patent JP2003532683
Kind Code:
A
Abstract:
In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal.
Inventors:
Tudan Christopher Earl.
Marzog Ahmed
Areb Lekder
Successor
Eaves Connie Jay.
Cashman joanne
Clark-Louis Ian
Salari Hassan
Marzog Ahmed
Areb Lekder
Successor
Eaves Connie Jay.
Cashman joanne
Clark-Louis Ian
Salari Hassan
Application Number:
JP2001581849A
Publication Date:
November 05, 2003
Filing Date:
May 09, 2001
Export Citation:
Assignee:
THE UNIVERSITY OF BRITISH COLUMBIA
Chemokine Therapeutics Corporation
Chemokine Therapeutics Corporation
International Classes:
A61K38/00; A61K38/10; A61K38/17; A61K45/00; A61K48/00; A61P35/00; A61P37/00; A61P37/06; A61P43/00; C07K7/06; C07K7/08; C07K14/00; C07K14/47; C07K14/52; C12N5/0789; (IPC1-7): A61K45/00; A61K38/00; A61K48/00; A61P35/00; A61P37/06; A61P43/00; C12N5/06
Attorney, Agent or Firm:
Shimizu Hatsushi (1 person outside)